The Pulmonary Vasculature in Chronic Lung Disease

This book comprehensively covers pulmonary vascular disease and its relation to lung disease. Pulmonary vascular disease is a major complication of all types of lung disease including smoking related lung disease (COPD, emphysema) and interstitial lung disease, serving as significant source of morbidity and mortality in these patients. The co-evolution of lung disease and vascular disease is a very interesting area of research activity in an attempt both to understand and seek treatments for disease of the lung as well as to risk stratify and prevent the development of pulmonary hypertension i...

Weiterlesen / Aufklappen

Farbod N. Rahaghi: Dr. Rahaghi earned his undergraduate degree in physics, masters and doctoral degrees in bioengineering, and medical degree from the University of California, San Diego. He then completed his internship and residency in internal medicine at Duke University Hospital Center before moving to Boston, where he completed a clinical fellowship in pulmonary and critical care medicine followed by a research fellowship. Dr. Rahaghi's research focuses on topics including evaluation of investigational therapies for pulmonary arterial hypertension and the role of computed tomography in assessing pulmonary hypertension. He serves as a reviewer for the American Journal of Respiratoryand Critical Care Medicine, CHEST, Circulation, and other publications. Dr. Rahaghi is a member of the American Thoracic Society, American College of Chest Physicians, Pulmonary Vascular research Institute, and several other professional organizations. Laszlo Farkas: Born in Budapest/Hungary, Dr. Farkas obtained his education including Medical School and Doctoral Thesis in Regensburg, Germany. After focusing on clinical training in Internal Medicine at the University Hospital of the University of Regensburg, Dr. Farkas joined Dr. Martin Kolb at McMaster University for postdoctoral research training in lung tissue and vascular injury. After a short training period at Virginia Commonwealth University, Dr. Farkas joined the Faculty in the Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine to establish his pulmonary vascular disease laboratory. In 2019, Dr. Farkas relocated to The Ohio State University to expand his research program. Dr. Farkas' research program focuses on the central role that altered endothelial cell function plays in lung vascular remodelling and pulmonary hypertension. Of particular interest are molecular pathways regulating endothelial cell function, including Toll-like receptor 3. He serves as editor for Frontiers in Pediatrics, PlosONE and the International Journal of Molecular Sciences and as reviewer for many prestigious journal including the American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, Nature Cardiovascular Research, Science Advances, Journal of Clinical Investigation, Circulation and Circulation Research. Dr. Farkas is a member of the American Heart Association, the American Thoracic Society and the American Physiological Society. Oksana Shlobin: Oksana A. Shlobin, MD, FCCP, serves as Medical Director for the Pulmonary Hypertension Program and Director of Outreach and Education for the Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. She is also an Associate Professor of Medical Education at the University of Virginia. Dr. Shlobin is board certified in pulmonary and critical care medicine. Dr. Shlobin has been actively involved in clinicalresearch both during her fellowship and her tenure at Inova. She is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. Her research interests include pulmonary hypertension and interstitial lung diseases.

Produktdetails